Literature DB >> 29146701

Mesangial C4d Deposits in Early IgA Nephropathy.

Alfons Segarra1, Katheryne Romero2, Irene Agraz2, Natalia Ramos2, Alvaro Madrid3, Clara Carnicer4, Elias Jatem5, Ramón Vilalta3, Luis Enrique Lara3, Elena Ostos5, Naiara Valtierra5, Juliana Jaramillo2, Karla V Arredondo2, Gema Ariceta3, Cristina Martinez6.   

Abstract

BACKGROUND AND OBJECTIVES: The prognostic value of mesangial C4d deposits in IgA nephropathy has been analyzed in patients with reduced GFR but has not been analyzed in those with normal kidney function. The main objective of the study was to analyze the prognostic value of C4d deposits and association with response to treatment in patients with IgA nephropathy and normal GFR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study included 190 patients with idiopathic IgA nephropathy diagnosed by kidney biopsy between 1988 and 2005. The patients had GFR≥80 ml/min per 1.73 m2 at the time of diagnosis, and they had a paraffin-embedded kidney biopsy with eight glomeruli available.
RESULTS: In total, 170 (89%) and 20 (11%) patients were >18 and <18 years old, respectively; median (interquartile range) follow-up was 15 (12-22) years. Mesangial C4d deposit prevalence was 20% (38 of 190). At diagnosis, C4d-positive versus -negative patients had higher protein-to-creatinine ratio (median [interquartile range]: 1.94 g/g [0.9-3.1] versus 1.45 g/g [0.9-2.2]; P=0.04). During follow-up, C4d-positive patients showed a higher number of nephritic flares (median [range]: 1.4 [0-5] versus 0.9 [0-2]; P=0.04), had a higher protein-to-creatinine ratio (median [interquartile range]: 1.32 g/g [0.7-1.7] versus 0.89 g/g [0.1-1.3]; P<0.01), were more prone to receive repeated treatment with corticosteroids (45% versus 24%; P<0.01), and showed a larger reduction in eGFR (-1.6 versus -0.8 ml/min per 1.73 m2 per year; P=0.04). Furthermore, the presence of mesangial C4d deposits was an independent predictor of long-term kidney survival.
CONCLUSIONS: C4d deposits may be one of the earliest poor prognostic variables available for patients with idiopathic IgA nephropathy and normal kidney function at the time of diagnosis. However, Cd4 deposits alone are not associated with the response to angiotensin blockers or corticosteroid treatment.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  Adrenal Cortex Hormones; Biopsy; C4d deposits; Follow-Up Studies; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; IgA nephropathy; Kidney Glomerulus; Paraffin; Prevalence; Renal Insufficiency, Chronic; Retrospective Studies; complement activation; creatinine; glomerular filtration rate; kidney; lectin-pathway; prognosis

Mesh:

Substances:

Year:  2017        PMID: 29146701      PMCID: PMC5967419          DOI: 10.2215/CJN.02530317

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  25 in total

Review 1.  IgA nephropathy.

Authors:  Robert J Wyatt; Bruce A Julian
Journal:  N Engl J Med       Date:  2013-06-20       Impact factor: 91.245

Review 2.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

3.  Predicting progression in IgA nephropathy.

Authors:  L P Bartosik; G Lajoie; L Sugar; D C Cattran
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

4.  Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Authors:  Rosanna Coppo; Danilo Lofaro; Roberta R Camilla; Shubha Bellur; Daniel Cattran; H Terence Cook; Ian S D Roberts; Licia Peruzzi; Alessandro Amore; Francesco Emma; Laura Fuiano; Ulla Berg; Rezan Topaloglu; Yelda Bilginer; Loreto Gesualdo; Rosaria Polci; Malgorzata Mizerska-Wasiak; Yasar Caliskan; Sigrid Lundberg; Giovanni Cancarini; Colin Geddes; Jack Wetzels; Andrzej Wiecek; Magdalena Durlik; Stefano Cusinato; Cristiana Rollino; Milena Maggio; Manuel Praga; Hilde K Smerud; Vladimir Tesar; Dita Maixnerova; Jonathan Barratt; Teresa Papalia; Renzo Bonofiglio; Gianna Mazzucco; Costantinos Giannakakis; Magnus Soderberg; Diclehan Orhan; Anna Maria Di Palma; Jadwiga Maldyk; Yasemin Ozluk; Birgitta Sudelin; Regina Tardanico; David Kipgen; Eric Steenbergen; Henryk Karkoszka; Agnieszka Perkowska-Ptasinska; Franco Ferrario; Eduardo Gutierrez; Eva Honsova
Journal:  Pediatr Nephrol       Date:  2016-08-25       Impact factor: 3.714

5.  The Oxford classification of IgA nephropathy: single centre experience.

Authors:  Ladislava Grcevska; Vesna Ristovska; Vladimir Nikolov; Gordana Petrusevska; Maja Milovanceva-Popovska; Momir Polenakovic
Journal:  Prilozi       Date:  2010

6.  Human IgA activates the complement system via the mannan-binding lectin pathway.

Authors:  A Roos; L H Bouwman; D J van Gijlswijk-Janssen; M C Faber-Krol; G L Stahl; M R Daha
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

7.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Authors:  Ian S D Roberts; H Terence Cook; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Daniel C Cattran; Rosanna Coppo; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; John Feehally; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

8.  Remission of proteinuria improves prognosis in IgA nephropathy.

Authors:  Heather N Reich; Stéphan Troyanov; James W Scholey; Daniel C Cattran
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

9.  Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.

Authors:  Mario Espinosa; Rosa Ortega; Jose Manuel Gómez-Carrasco; Fernando López-Rubio; María López-Andreu; María Ovidia López-Oliva; Pedro Aljama
Journal:  Nephrol Dial Transplant       Date:  2008-10-08       Impact factor: 5.992

Review 10.  Markers for the progression of IgA nephropathy.

Authors:  Dita Maixnerova; Colin Reily; Qi Bian; Michaela Neprasova; Jan Novak; Vladimir Tesar
Journal:  J Nephrol       Date:  2016-05-03       Impact factor: 3.902

View more
  12 in total

Review 1.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

2.  Association between glomerular C4d deposition, proteinuria, and disease severity in children with IgA nephropathy.

Authors:  Hui Wang; Shuzhen Sun; Weiran Zhou; Ying Shen; Xuemei Liu; Junhui Zhen; Hongxia Zhang; Fan Duan; Yanyan Pan; Linlin Dong
Journal:  Pediatr Nephrol       Date:  2022-09-14       Impact factor: 3.651

3.  Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy.

Authors:  Dan Wu; Xueqian Li; Xingfeng Yao; Nan Zhang; Lei Lei; Hejia Zhang; Mengmeng Tang; Jie Ni; Chen Ling; Zhi Chen; Xiangmei Chen; Xiaorong Liu
Journal:  Clin Exp Nephrol       Date:  2021-02-23       Impact factor: 2.801

4.  Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival.

Authors:  Michael Eder; Nicolas Kozakowski; Haris Omic; Christof Aigner; Johannes Kläger; Brian Perschl; Roman Reindl-Schwaighofer; Gregor Bond; Georg A Böhmig; Željko Kikić
Journal:  J Nephrol       Date:  2020-12-11       Impact factor: 3.902

Review 5.  The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?

Authors:  Felix Poppelaars; Bernardo Faria; Wilhelm Schwaeble; Mohamed R Daha
Journal:  J Clin Med       Date:  2021-10-14       Impact factor: 4.241

6.  Glomerular C4d Deposition and Kidney Disease Progression in IgA Nephropathy: A Systematic Review and Meta-analysis.

Authors:  Yuanyuan Jiang; Jincan Zan; Sufang Shi; Wanyin Hou; Wenjing Zhao; Xuhui Zhong; Xujie Zhou; Jicheng Lv; Hong Zhang
Journal:  Kidney Med       Date:  2021-08-06

Review 7.  Complement activation in IgA nephropathy.

Authors:  Nicholas R Medjeral-Thomas; H Terence Cook; Matthew C Pickering
Journal:  Semin Immunopathol       Date:  2021-08-11       Impact factor: 9.623

8.  Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies.

Authors:  Cinthia B Drachenberg; John C Papadimitriou; Preeti Chandra; Abdolreza Haririan; Susan Mendley; Matthew R Weir; Mario F Rubin
Journal:  Kidney Int Rep       Date:  2019-07-30

9.  Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy.

Authors:  Precil Diego Miranda de Menezes Neves; Rafael A Souza; Fábio M Torres; Fábio A Reis; Rafaela B Pinheiro; Cristiane B Dias; Luis Yu; Viktoria Woronik; Luzia S Furukawa; Lívia B Cavalcante; Stanley de Almeida Araújo; David Campos Wanderley; Denise M Malheiros; Lectícia B Jorge
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

10.  Clinicopathological significance of glomerular capillary IgA deposition in childhood IgA nephropathy.

Authors:  Yuko Shima; Koichi Nakanishi; Hironobu Mukaiyama; Yu Tanaka; Takuzo Wada; Ryojiro Tanaka; Hiroshi Kaito; Kandai Nozu; Mayumi Sako; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2020-10-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.